Related Articles
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas
Pilot study of WT1 peptide‑pulsed dendritic cell vaccination with docetaxel in esophageal cancer
Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70